BDX fundamentals
Becton, Dickinson and Company revenue breakdown overview
Becton, Dickinson and Company revenue for the last year amounted to 20.18 B USD, the most of which — 10.07 B USD — came from its highest performing source at the moment, Medical, the year earlier bringing 9.50 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought Becton, Dickinson and Company 11.66 B USD, and the year before that — 11.11 B USD.
By source
2017
2018
2019
2020
2021
2022
2023
2024
0.00
5.50 B
11.00 B
16.50 B
22.00 B
Medical
Life Sciences
Interventional
Currency: USD
2017
2018
2019
2020
2021
2022
2023
2024
Medical
8.68 B
9.48 B
8.84 B
9.50 B
10.07 B
Life Sciences
4.67 B
6.53 B
5.56 B
5.13 B
5.19 B
Interventional
3.76 B
4.24 B
4.46 B
4.74 B
4.98 B
By country
2017
2018
2019
2020
2021
2022
2023
2024
0.00
5.50 B
11.00 B
16.50 B
22.00 B
United States
EMEA
Greater Asia
Other
Europe
Currency: USD
2017
2018
2019
2020
2021
2022
2023
2024
United States
9.72 B
10.97 B
10.72 B
11.11 B
11.66 B
EMEA
—
4.75 B
4.04 B
4.24 B
4.40 B
Greater Asia
2.57 B
3.27 B
3.05 B
2.91 B
2.91 B
Other
1.35 B
1.25 B
1.06 B
1.10 B
1.21 B
Europe
3.48 B
—
—
—
—